Provided by Tiger Trade Technology Pte. Ltd.

Aptevo Therapeutics

2.68
-0.0800-2.90%
Post-market: 2.690.0053+0.20%19:45 EDT
Volume:55.29K
Turnover:148.64K
Market Cap:4.83M
PE:-0.09
High:2.85
Open:2.84
Low:2.58
Close:2.76
52wk High:48.78
52wk Low:2.58
Shares:1.80M
Float Shares:1.64M
Volume Ratio:0.81
T/O Rate:3.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.4999
EPS(LYR):-82.2951
ROE:-420.34%
ROA:-111.49%
PB:0.80
PE(LYR):-0.03

Loading ...

Aptevo Therapeutics files to sell 6.44M shares of common stock for holders

TIPRANKS
·
Aug 22

Aptevo Therapeutics Held Annual Shareholder Meeting

Reuters
·
Aug 22

Analysts Offer Insights on Healthcare Companies: Aptevo Therapeutics (APVO) and Jasper Therapeutics (JSPR)

TIPRANKS
·
Aug 18

Aptevo Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Aptevo Therapeutics Q2 EPS $(5.31) Beats $(6.16) Estimate

Benzinga Earnings
·
Aug 14

Aptevo Net Loss Widens to $13.1 Million in FY26 H1; Operating Cash Outflow Narrows to $13.4 Million

Reuters
·
Aug 14

Aptevo Wins $1.5 Million CARE Fund Grant for Apvo451 IND-Enabling Work

Reuters
·
Aug 14

Aptevo Names Mary Janatpour Chief Scientific Officer

Reuters
·
Aug 14

Aptevo Therapeutics Raises Capital Through Warrant-Induced Financing

TIPRANKS
·
Aug 14

Aptevo Therapeutics Says Holders Exercise Existing Warrants for 254,922 Shares at USD 4.03 Each

Reuters
·
Aug 14

Aptevo Therapeutics Says Warrant Holders Exercise for Cash at USD 4.03 Per Share

Reuters
·
Aug 12

Aptevo Therapeutics Inc Expected to Post a Loss of $6.01 a Share - Earnings Preview

Reuters
·
Aug 07

Aptevo Therapeutics Announces Annual Shareholder Meeting

Reuters
·
Aug 01

Aptevo Therapeutics - Announces New Solid Tumor Strategy - SEC Filing

THOMSON REUTERS
·
Jul 28

Aptevo Therapeutics - Files Patent Application for Nectin-4 X Pd-L1 Dual-Targeting Backbone - SEC Filing

THOMSON REUTERS
·
Jul 28

Aptevo Files Patent for Nectin-4 X PD-L1 Dual-targeting Backbone for Solid Tumor Therapies

Reuters
·
Jul 27

Aptevo Therapeutics Secures Grant for APVO451 Development

TIPRANKS
·
Jul 01

Aptevo Therapeutics - Enters Grant Award Agreement with Andy Hill Care Fund - SEC Filing

THOMSON REUTERS
·
Jul 01

Aptevo Therapeutics - Care Fund to Provide $1.5 Mln Funding for Apvo451 Ind-enabling Studies - SEC Filing

THOMSON REUTERS
·
Jul 01

Aptevo Wins $1.5 Million Andy Hill CARE Fund Grant for Apvo451 Ind-enabling Work

Reuters
·
Jun 30